VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹14 Cr | ₹16 Cr | ₹11 Cr | ₹11 Cr | ₹-0.68 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹14 Cr |
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹-0.68 Cr |
How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 Cr | -7.99 | |
| Mar2025 | ₹16 Cr | 42.73 | |
| Mar2024 | ₹11 Cr | 2.54 | |
| Mar2023 | ₹11 Cr | Positive | |
| Mar2022 | ₹-0.68 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,099.2 Cr | -0.2% | -11.3% | 204.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -0.2% |
-11.3% |
204.1% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses